The investigators subsequently monitored the long-term effects of dose-adjusted satavaptan treatment in the same group of patients with SIADH. Ten patients completed the 12-month open-label study ...

According to Palmer (2000), SIADH is an expansion of extracellular fluid volume resulting from the superfluous release of antidiuretic hormone (ADH) or increased renal sensitivity to ADH.

This came after MSN Laboratories presented the literature on additional efficacy data on Tolvaptan tablets 7.5 mg, approved ...